InsiderClue
Insiders · Profile

Gosebruch Henry O

President & CEO at Neumora Therapeutics · EVP, Chief Strategy Officer at AbbVie. Filing since 31 Jul 2017. CIK 0001659625

NMRA Neumora Therapeutics, Inc. President & CEO · 1 trade ABBV AbbVie EVP, Chief Strategy Officer · 8 trades
Company
Date
Role
Action
Shares
Amount
Of holding
NMRA Neumora Therapeutics, Inc.
19 Sep 2023
President & CEO
Bought
15,000
$189.37K
opened
ABBV AbbVie
16 May 2022
EVP, Chief Strategy Officer
Sold, plan not stated
83,960
$13.01M
83.5%
ABBV AbbVie
1 Mar 2022
EVP, Chief Strategy Officer
Sold, plan not stated
40,000
$5.91M
70.6%
ABBV AbbVie
20 Nov 2020
EVP, Chief Strategy Officer
Sold, plan not stated
33,100
$3.29M
62.3%
ABBV AbbVie
20 Nov 2020
EVP, Chief Strategy Officer
Sold, plan not stated
6,900
$681.93K
11.5%
ABBV AbbVie
29 Jul 2019
EVP, Chief Strategy Officer
Bought
30,000
$2.02M
65.6%
ABBV AbbVie
29 Nov 2018
EVP, Chief Strategy Officer
Sold, plan not stated
42,450
$3.82M
58.3%
ABBV AbbVie
30 Oct 2017
Chief Strategy Officer
Sold, plan not stated
18,300
$1.66M
21.9%
ABBV AbbVie
31 Jul 2017
Chief Strategy Officer
Sold, plan not stated
18,300
$1.28M
18.0%
9 decisions on file.